Zhang Weilong について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Collaborative Innovation Center for Cancer Medicine; Third Hospital, Peking University, Beijing, China について
He Huan について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zang Mengya について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wu Qifeng について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zhao Hong について
Department of Abdominal Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Lu Ling-ling について
Qidong People’s Hospital and Qidong Liver Cancer Institute, Qidong, Jiangsu Province, China について
Ma Peiqing について
Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zheng Hongwei について
Qidong People’s Hospital and Qidong Liver Cancer Institute, Qidong, Jiangsu Province, China について
Wang Nengjin について
Qidong People’s Hospital and Qidong Liver Cancer Institute, Qidong, Jiangsu Province, China について
Zhang Ying について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
He Siyuan について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Chen Xiaoyan について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wu Zhiyuan について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wang Xiaoyue について
State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China について
Cai Jianqiang について
Department of Abdominal Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Liu Zhihua について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Sun Zongtang について
State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zeng Yi-Xin について
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center ... について
Qu Chunfeng について
State Key Lab of Molecular Oncology, Immunology Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colleges, Beijing, China について
Jiao Yuchen について
State Key Lab of Molecular Oncology, Laboratory of Cell and Molecular Biology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Collaborative Innovation Center for Cancer Medicine, Beijing, China について
Gastroenterology について
ヌクレオチド配列 について
中華人民共和国 について
腫瘍細胞 について
患者 について
病因 について
危険因子 について
突然変異 について
遺伝 について
アフラトキシン について
日本 について
肝細胞癌 について
発癌物質 について
ゲノム について
リンパ球 について
治療法 について
消化器の腫よう について
発癌機序・因子 について
アフラトキシン について
肝細胞癌 について
遺伝 について